Dr. Collins awarded CIHR Project Grant

Date Posted: 
2021-03-04
Dr. Colin Collins

Dr. Colin Collins has been awarded a five-year CIHR Project Grant for "Uncovering early mediators of lineage plasticity and validation of a metabolic vulnerability in neuroendocrine prostate cancer" (co-investigators: Dr. YZ Wang and Dr. Martin Gleave). 

This project will study two potential therapeutic approaches aimed at  preventing the onset of neuroendocrine prostate cancer (NEPC), which currently has no effective therapies for treatment or prevention.  Adenocarcinoma of the prostate ultimately progresses to castrate-resistant prostate cancer, which can become lethal NEPC through the process of neuroendocrine transdifferentiation (NEtD). By testing the effect of blocking pathways supsected to cause NEtD in model systems, the aim is to discover novel therapeutic targets.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Employment

Work at the Vancouver Prostate Centre

Monday, November 1, 2021

Dr. Syam Somasekharan appointed Senior Research Scientist

Dr. Syam Somasekharan
Wednesday, September 8, 2021

Recent publication proposes a potential new therapeutic approach to treatment-resistant prostate cancer